testosterone
Generic: testosterone
Labeler: cipla usa inc.Drug Facts
Product Profile
Brand Name
testosterone
Generic Name
testosterone
Labeler
cipla usa inc.
Dosage Form
SOLUTION
Routes
Active Ingredients
testosterone 30 mg/1.5mL
Manufacturer
Identifiers & Regulatory
Product NDC
69097-363
Product ID
69097-363_ce2732a6-d90e-442c-b7d0-dc1d65a7e3cc
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA209533
DEA Schedule
ciii
Listing Expiration
2026-12-31
Marketing Start
2018-03-30
Pharmacologic Class
Established (EPC)
Mechanism of Action
Chemical Structure
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
69097363
Hyphenated Format
69097-363
Supplemental Identifiers
RxCUI
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
testosterone (source: ndc)
Generic Name
testosterone (source: ndc)
Application Number
ANDA209533 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 30 mg/1.5mL
Packaging
- 1 BOTTLE in 1 CARTON (69097-363-44) / 90 mL in 1 BOTTLE
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["TOPICAL"], "spl_id": "ce2732a6-d90e-442c-b7d0-dc1d65a7e3cc", "openfda": {"nui": ["N0000175824", "N0000000146", "M0001109"], "unii": ["3XMK78S47O"], "rxcui": ["1599949"], "spl_set_id": ["6a46b5de-5d95-4570-91a6-3e4278028c59"], "pharm_class_cs": ["Androstanes [CS]"], "pharm_class_epc": ["Androgen [EPC]"], "pharm_class_moa": ["Androgen Receptor Agonists [MoA]"], "manufacturer_name": ["Cipla USA Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE in 1 CARTON (69097-363-44) / 90 mL in 1 BOTTLE", "package_ndc": "69097-363-44", "marketing_start_date": "20180330"}], "brand_name": "Testosterone", "product_id": "69097-363_ce2732a6-d90e-442c-b7d0-dc1d65a7e3cc", "dosage_form": "SOLUTION", "pharm_class": ["Androgen Receptor Agonists [MoA]", "Androgen [EPC]", "Androstanes [CS]"], "product_ndc": "69097-363", "dea_schedule": "CIII", "generic_name": "Testosterone", "labeler_name": "Cipla USA Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Testosterone", "active_ingredients": [{"name": "TESTOSTERONE", "strength": "30 mg/1.5mL"}], "application_number": "ANDA209533", "marketing_category": "ANDA", "marketing_start_date": "20180330", "listing_expiration_date": "20261231"}